{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:36:40Z","timestamp":1787639800375,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jogoh.2020.101928","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T11:12:09Z","timestamp":1601723529000},"page":"101928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Negative estrogen receptors and positive progesterone receptors breast cancers"],"prefix":"10.1016","volume":"50","author":[{"given":"Julie","family":"Delvall\u00e9e","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Etienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavie","family":"Arbion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vild\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Body","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lobna","family":"Ouldamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"November (6)","key":"10.1016\/j.jogoh.2020.101928_bib0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jogoh.2020.101928_bib0010","unstructured":"Les donn\u00e9es - Institut National Du cancer [Internet]. [cited 2017 Jul 12]. http:\/\/www.e-cancer.fr\/Expertises-et-publications\/Catalogue-des-publications\/Guide-ALD-Cancer-de-l-ovaire."},{"issue":"6","key":"10.1016\/j.jogoh.2020.101928_bib0015","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1634\/theoncologist.9-6-606","article-title":"Prognostic and predictive factors in early-stage breast cancer","volume":"9","author":"Cianfrocca","year":"2004","journal-title":"Oncologist"},{"issue":"Mars (3)","key":"10.1016\/j.jogoh.2020.101928_bib0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/annonc\/mds430","article-title":"Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse","volume":"24","author":"Cancello","year":"2013","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"issue":"January (2)","key":"10.1016\/j.jogoh.2020.101928_bib0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1200\/JCO.2012.43.4134","article-title":"Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer","volume":"31","author":"Prat","year":"2013","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"10.1016\/j.jogoh.2020.101928_bib0030","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jclinpath-2016-203847","article-title":"Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group","volume":"70","author":"Ahmed","year":"2017","journal-title":"J Clin Pathol. avr"},{"issue":"Mai (9)","key":"10.1016\/j.jogoh.2020.101928_bib0035","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1200\/JCO.2004.99.251","article-title":"Time to stop progesterone receptor testing in breast cancer management","volume":"22","author":"Olivotto","year":"2004","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"January (1)","key":"10.1016\/j.jogoh.2020.101928_bib0040","article-title":"Clinicopathological characteristics and breast cancer-specific survival of patients with single hormone receptor-positive breast cancer","volume":"3","author":"Li","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"March 18","key":"10.1016\/j.jogoh.2020.101928_bib0045","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12885-015-1121-4","article-title":"Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer","volume":"15","author":"Bae","year":"2015","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.jogoh.2020.101928_bib0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1200\/JCO.2012.43.4134","article-title":"Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer","volume":"31","author":"Prat","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jogoh.2020.101928_bib0055","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-020-08898-5","article-title":"Single hormone receptor positive breast cancers have distinct characteristics and survival","author":"Dauphine","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jogoh.2020.101928_bib0060","unstructured":"CIM-10 FR 2015 \u00e0 usage PMSI | Publication ATIH [Internet]. Available from: http:\/\/www.atih.sante.fr\/cim-10-fr-2015-usage-pmsi."},{"key":"10.1016\/j.jogoh.2020.101928_bib0065","author":"Organization"},{"issue":"November (9)","key":"10.1016\/j.jogoh.2020.101928_bib0070","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/1097-0142(19891101)64:9<1914::AID-CNCR2820640926>3.0.CO;2-G","article-title":"Prognostic value of histologic grade nuclear components of Scarff-Bloom- Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas","volume":"64","author":"Le Doussal","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.jogoh.2020.101928_bib0075","unstructured":"http:\/\/www.asco.org\/practice-guidelines\/quality-guidelines\/guidelines\/gynecologic-cancer#\/13091."},{"key":"10.1016\/j.jogoh.2020.101928_bib0080","unstructured":"Logiciel R version 3.1.2 (package Hmisc, Design and Survival libraries) [Internet]. Available from: http:\/\/www.cran.r-project.org\/."},{"issue":"Juill (7)","key":"10.1016\/j.jogoh.2020.101928_bib0085","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.5858\/134.7.e48","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)","volume":"134","author":"Hammond","year":"2010","journal-title":"Arch Pathol Lab Med"},{"issue":"Ao\u00fbt (8)","key":"10.1016\/j.jogoh.2020.101928_bib0090","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","article-title":"Tailoring therapies--improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast cancer 2015","volume":"26","author":"Coates","year":"2015","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"1\u20133","key":"10.1016\/j.jogoh.2020.101928_bib0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1006133418245","article-title":"Time-dependence of hazard ratios for prognostic factors in primary breast cancer","volume":"52","author":"Hilsenbeck","year":"1998","journal-title":"Breast Cancer Res Treat"},{"issue":"Ao\u00fbt (9793)","key":"10.1016\/j.jogoh.2020.101928_bib0100","first-page":"771","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"Davies","year":"2011","journal-title":"Lancet Lond Engl"},{"issue":"Juin (11)","key":"10.1016\/j.jogoh.2020.101928_bib0105","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/cncr.21030","article-title":"Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma","volume":"103","author":"Grann","year":"2005","journal-title":"Cancer"},{"issue":"Juin (6)","key":"10.1016\/j.jogoh.2020.101928_bib0110","first-page":"613","article-title":"[A comparative study of hormone receptors in breast cancer with quantitative immunocytochemistry and biochemistry]","volume":"84","author":"Marcot","year":"1997","journal-title":"Bull Cancer (Paris)"},{"issue":"September (3)","key":"10.1016\/j.jogoh.2020.101928_bib0115","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12253-011-9366-y","article-title":"Estrogen receptor negative and progesterone receptor positive breast carcinomas-how frequent are they?","volume":"17","author":"Cserni","year":"2011","journal-title":"Pathol Oncol Res POR"},{"issue":"4","key":"10.1016\/j.jogoh.2020.101928_bib0120","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr3462","article-title":"Estrogen receptor negative\/progesterone receptor positive breast cancer is not a reproducible subtype","volume":"15","author":"Hefti","year":"2013","journal-title":"Breast Cancer Res BCR"},{"issue":"Mai (3)","key":"10.1016\/j.jogoh.2020.101928_bib0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1524-4741.2000.99097.x","article-title":"Assessment of tissue estrogen and progesterone receptor levels: a survey of current practice, techniques, and quantitation methods","volume":"6","author":"Layfield","year":"2000","journal-title":"Breast J"},{"issue":"Janv (2)","key":"10.1016\/j.jogoh.2020.101928_bib0130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1200\/JCO.2007.14.8411","article-title":"Does estrogen receptor negative\/progesterone receptor positive breast carcinoma exist?","volume":"26","author":"De Maeyer","year":"2008","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"Janv (1)","key":"10.1016\/j.jogoh.2020.101928_bib0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1309\/4WV79N2GHJ3X1841","article-title":"Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers","volume":"123","author":"Nadji","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"October (30)","key":"10.1016\/j.jogoh.2020.101928_bib0140","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1200\/JCO.2007.12.2747","article-title":"Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype","volume":"25","author":"Rakha","year":"2007","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"Janv (1)","key":"10.1016\/j.jogoh.2020.101928_bib0145","first-page":"105","article-title":"Variant human breast tumor estrogen receptor with constitutive transcriptional activity","volume":"51","author":"Fuqua","year":"1991","journal-title":"Cancer Res"},{"issue":"F\u00e9vr (4)","key":"10.1016\/j.jogoh.2020.101928_bib0150","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1200\/JCO.2005.05.152","article-title":"Insights into the role of progesterone receptors in breast cancer","volume":"23","author":"Fuqua","year":"2005","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"Avr (2)","key":"10.1016\/j.jogoh.2020.101928_bib0155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10549-010-0746-x","article-title":"Combinatorial biomarker expression in breast cancer","volume":"120","author":"Rakha","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"Mars (12)","key":"10.1016\/j.jogoh.2020.101928_bib0160","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJM199403243301201","article-title":"Adjuvant systemic therapy and survival after breast cancer","volume":"330","author":"Olivotto","year":"1994","journal-title":"N Engl J Med"},{"issue":"Mai (10)","key":"10.1016\/j.jogoh.2020.101928_bib0165","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1200\/JCO.2003.09.099","article-title":"Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases","volume":"21","author":"Bardou","year":"2003","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"D\u00e9c (12)","key":"10.1016\/j.jogoh.2020.101928_bib0170","first-page":"1545","article-title":"Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study","volume":"17","author":"Mohsin","year":"2004","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"D\u00e9c (6)","key":"10.1016\/j.jogoh.2020.101928_bib0175","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.breast.2009.09.002","article-title":"The prognostic significance of single hormone receptor positive metastatic breast cancer: an analysis of three randomised phase III trials of aromatase inhibitors","volume":"18","author":"Stuart-Harris","year":"2009","journal-title":"Breast Edinb Scotl"},{"issue":"Mai (5)","key":"10.1016\/j.jogoh.2020.101928_bib0180","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/annonc\/mdl016","article-title":"Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status","volume":"17","author":"Dowsett","year":"2006","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"Nov (11)","key":"10.1016\/j.jogoh.2020.101928_bib0185","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jcp.2005.027185","article-title":"Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial","volume":"58","author":"Jirstr\u00f6m","year":"2005","journal-title":"J Clin Pathol"},{"issue":"Juin (16)","key":"10.1016\/j.jogoh.2020.101928_bib0190","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1200\/JCO.2005.05.203","article-title":"It is not time to stop progesterone receptor testing in breast cancer","volume":"23","author":"Colomer","year":"2005","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"10.1016\/j.jogoh.2020.101928_bib0195","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02893416","article-title":"Estrogen receptor alpha-negative and progesterone receptor-positive breast cancer: lab error or real entity?","volume":"12","author":"Kiani","year":"2006","journal-title":"Pathol Oncol Res POR"},{"issue":"October","key":"10.1016\/j.jogoh.2020.101928_bib0200","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12916-015-0496-z","article-title":"Molecular essence and endocrine responsiveness of estrogen receptor- negative, progesterone receptor-positive, and HER2-negative breast cancer","volume":"13","author":"Yu","year":"2015","journal-title":"BMC Med"},{"issue":"September (9)","key":"10.1016\/j.jogoh.2020.101928_bib0205","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/jcp.53.9.688","article-title":"Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening","volume":"53","author":"Rhodes","year":"2000","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.jogoh.2020.101928_bib0210","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.7314\/APJCP.2012.13.4.1111","article-title":"The estrogen receptor negative-progesterone receptor positive breast carcinoma is a biological entity and not a technical artifact","volume":"13","author":"Ng","year":"2012","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"7","key":"10.1016\/j.jogoh.2020.101928_bib0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132449","article-title":"Outcomes of estrogen receptor negative and progesterone receptor positive breast cancer","volume":"10","author":"Chan","year":"2015","journal-title":"PLoS One"},{"issue":"Mars","key":"10.1016\/j.jogoh.2020.101928_bib0220","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12885-015-1121-4","article-title":"Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer","volume":"15","author":"Bae","year":"2015","journal-title":"BMC Cancer"},{"issue":"Nov (11)","key":"10.1016\/j.jogoh.2020.101928_bib0225","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.humpath.2015.07.019","article-title":"Characterization of estrogen receptor-negative\/progesterone receptor- positive breast cancer","volume":"46","author":"Shen","year":"2015","journal-title":"Hum Pathol"},{"issue":"Juin (3)","key":"10.1016\/j.jogoh.2020.101928_bib0230","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1006011328655","article-title":"Estrogen receptor negative and progesterone receptor positive primary breast cancer: pathological characteristics and clinical outcome","volume":"49","author":"Bernoux","year":"1998","journal-title":"Institut Curie Breast Cancer Study Group. Breast Cancer Res Treat"},{"issue":"D\u00e9c (12)","key":"10.1016\/j.jogoh.2020.101928_bib0235","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00432-008-0414-2","article-title":"Breast cancer patients with estrogen receptor-negative\/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment","volume":"134","author":"Yu","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"issue":"Janv (1)","key":"10.1016\/j.jogoh.2020.101928_bib0240","first-page":"95","article-title":"The oestrogen receptor-negative\/progesterone receptor-positive breast tumour: a biological entity or a technical artefact?","volume":"62","author":"Rhodes","year":"2009","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.jogoh.2020.101928_bib0245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4048\/jbc.2010.13.1.74","article-title":"The clinicopathologic characteristics and clinical outcomes of estrogen receptor negative and progesterone receptor positive breast cancer","volume":"13","author":"Jeon","year":"2010","journal-title":"J Breast Cancer [Internet]"},{"issue":"Juill (2)","key":"10.1016\/j.jogoh.2020.101928_bib0250","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ijc.2910620205","article-title":"Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features","volume":"62","author":"Bonnier","year":"1995","journal-title":"Int J Cancer"},{"issue":"Mai (5)","key":"10.1016\/j.jogoh.2020.101928_bib0255","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1200\/JCO.1994.12.5.888","article-title":"Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer","volume":"12","author":"Nixon","year":"1994","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"Juill (20)","key":"10.1016\/j.jogoh.2020.101928_bib0260","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","article-title":"Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression","volume":"26","author":"Anders","year":"2008","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"F\u00e9vr (3)","key":"10.1016\/j.jogoh.2020.101928_bib0265","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/jnci\/djh025","article-title":"Risk factors for breast cancer according to estrogen and progesterone receptor status","volume":"96","author":"Colditz","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"Janv (1)","key":"10.1016\/j.jogoh.2020.101928_bib0270","first-page":"3","article-title":"[Invasive lobular carcinoma of the breast: specific diagnosis and evolution]","volume":"34","author":"Espie","year":"2006","journal-title":"Gynecol Obstet Fertil"},{"issue":"September (3)","key":"10.1016\/j.jogoh.2020.101928_bib0275","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4048\/jbc.2012.15.3.288","article-title":"Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients","volume":"15","author":"Yang","year":"2012","journal-title":"J Breast Cancer"},{"issue":"September","key":"10.1016\/j.jogoh.2020.101928_bib0280","doi-asserted-by":"crossref","first-page":"iv92","DOI":"10.1093\/annonc\/mdu327.19","article-title":"The only progesterone receptor positive breast cancer patients have totally different clinical features compared to triple negative counterparts: is it true?","volume":"25","author":"Yazici","year":"2014","journal-title":"Ann Oncol [Internet]"},{"issue":"November (46)","key":"10.1016\/j.jogoh.2020.101928_bib0285","doi-asserted-by":"crossref","first-page":"e2066","DOI":"10.1097\/MD.0000000000002066","article-title":"Prognostic significance of single progesterone receptor positivity: a comparison study of estrogen receptor Negative\/Progesterone receptor Positive\/Her2 negative primary breast cancer With triple negative breast cancer","volume":"94","author":"Fan","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"Janv (2)","key":"10.1016\/j.jogoh.2020.101928_bib0290","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-013-2763-z","article-title":"Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative\/progesterone receptor-positive breast cancers","volume":"143","author":"Itoh","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"Janv (1)","key":"10.1016\/j.jogoh.2020.101928_bib0295","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10549-015-3651-5","article-title":"Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative\/progesterone receptor-positive invasive breast cancer phenotype","volume":"155","author":"Schroth","year":"2016","journal-title":"Breast Cancer Res Treat"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784720302920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784720302920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:57:26Z","timestamp":1762855046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784720302920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2468784720302920"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2020.101928","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Negative estrogen receptors and positive progesterone receptors breast cancers","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2020.101928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101928"}}